scispace - formally typeset
M

Matti Nykter

Researcher at University of Tampere

Publications -  194
Citations -  13222

Matti Nykter is an academic researcher from University of Tampere. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 39, co-authored 167 publications receiving 10328 citations. Previous affiliations of Matti Nykter include Institute for Systems Biology & University of British Columbia.

Papers
More filters
Journal ArticleDOI

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse, +311 more
- 05 Nov 2015 - 
TL;DR: The Cancer Genome Atlas (TCGA) has been used for a comprehensive molecular analysis of primary prostate carcinomas as discussed by the authors, revealing substantial heterogeneity among primary prostate cancers, evident in the spectrum of molecular abnormalities and its variable clinical course.

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse, +309 more
TL;DR: A comprehensive molecular analysis of 333 primary prostate carcinomas revealed a molecular taxonomy in which 74% of these tumors fell into one of seven subtypes defined by specific gene fusions (ERG, ETV1/4, and FLI1) or mutations (SPOP, FOXA1, and IDH1).
Journal Article

The evolutionary history of lethal metastatic prostate cancer

TL;DR: Using whole-genome sequencing, multiple metastases arising from prostate tumours in ten patients are characterized and the complex patterns of metastatic spread are elucidate in detail and the development of resistance to androgen-deprivation therapy in prostate cancer is understood.
Journal ArticleDOI

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

TL;DR: It is proposed that plasma miR-141 may represent a novel biomarker that complements CEA in detecting colon cancer with distant metastasis and that high levels of miR -141 in plasma were associated with poor prognosis.